[HTML][HTML] Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside

LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - ncbi.nlm.nih.gov
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …

[HTML][HTML] Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

L Chen, J Qu, FS Kalyani, Q Zhang, L Fan… - Cellular and Molecular …, 2022 - Springer
As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …

[HTML][HTML] Mesenchymal stem cells in the treatment of COVID-19, a promising future

DG Beghini, SI Horita, A Henriques-Pons - Cells, 2021 - mdpi.com
Mesenchymal stem cells (MSCs) are multipotent adult stem cells present in virtually all
tissues; they have a potent self-renewal capacity and can differentiate into multiple cell …

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect

A Can, H Coskun - Stem Cells Translational Medicine, 2020 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused coronavirus
disease 2019 (COVID-19) pandemic has become a global health crisis with an extremely …

[HTML][HTML] Mesenchymal stem cells as a potential therapy for COVID-19

S Liu, D Peng, H Qiu, K Yang, Z Fu, L Zou - Stem cell research & therapy, 2020 - Springer
The outbreak of 2019 novel coronavirus disease (COVID-19) worldwide is becoming rapidly
a major concern. The number of severe cases has increased dramatically worldwide, while …

[HTML][HTML] Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research

A Coelho, RD Alvites, MV Branquinho… - Frontiers in cell and …, 2020 - frontiersin.org
In 2019, an outbreak of an unknown coronavirus–SARS-CoV-2–responsible for COVID-19
disease, was first reported in China, and evolved into a pandemic of huge dimensions and …

[HTML][HTML] Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19

M Jeyaraman, A John, S Koshy, R Ranjan… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) has been threatening the globe since
the end of November 2019. The disease revealed cracks in the health care system as health …

[HTML][HTML] Mesenchymal stem cell therapy for severe COVID-19

L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu… - Signal transduction and …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …

Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis

Z Li, S Niu, B Guo, T Gao, L Wang, Y Wang… - Cell …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 …

[HTML][HTML] Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19

A Klimczak - World journal of stem cells, 2020 - ncbi.nlm.nih.gov
The new coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
which emerged in December 2019 in Wuhan, China, has reached worldwide pandemic …